Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>APOE ε4</i> and Alzheimer's disease biomarkers in an American Indian community.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Long-term follow-up and response to elosulfase alfa in mucopolysaccharidosis type IVA: a single-center cohort from the Czech Republic.

Orphanet journal of rare diseases·2026
Same author

Long-term Natural History and Elosulfase Alfa Treatment for Mucopolysaccharidosis Type IVA: A Single-Center Study in the Czech Republic.

Research square·2026
Same author

Exploring delayed diagnosis in Gaucher disease: insights from a community survey and potential solutions.

Orphanet journal of rare diseases·2026
Same author

<i>APOE ε4</i> and ischemic heart disease in American Indian/Indigenous tribal Elders.

American heart journal plus : cardiology research and practice·2025
Same author

Body size and intracranial volume interact with the structure of the central nervous system: A multi-center in vivo neuroimaging study.

Imaging neuroscience (Cambridge, Mass.)·2025

Related Experiment Video

Updated: Feb 28, 2026

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease
05:53

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease

Published on: July 18, 2019

17.9K

Previously unrecognized behavioral phenotype in Gaucher disease type 3.

Magy Abdelwahab1, Michael Potegal1, Elsa G Shapiro1

  • 1Department of Pediatric Hematology (M.A.), Cairo University Pediatric Hospital, Egypt; and Program in Occupational Therapy (M.P.), and Division of Clinical Behavioral Neuroscience (E.G.S., I.N.), Department of Pediatrics, University of Minnesota, Minneapolis.

Neurology. Genetics
|June 22, 2017
PubMed
Summary

Patients with Gaucher disease type 3 (GD3) exhibit unique behavioral issues, primarily excessive anger and aggression. These behaviors correlate with IQ, potentially serving as markers for neurologic disease progression.

More Related Videos

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
11:05

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model

Published on: October 20, 2023

5.9K
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.4K

Related Experiment Videos

Last Updated: Feb 28, 2026

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease
05:53

Low-Cost Gait Analysis for Behavioral Phenotyping of Mouse Models of Neuromuscular Disease

Published on: July 18, 2019

17.9K
Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
11:05

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model

Published on: October 20, 2023

5.9K
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.4K

Area of Science:

  • Neuroscience
  • Genetics
  • Behavioral Science

Background:

  • Gaucher disease type 3 (GD3) is a rare genetic disorder with significant neurological manifestations.
  • Abnormal behaviors are frequently observed in GD3 patients, but their specific patterns and correlations are not fully understood.

Purpose of the Study:

  • To comprehensively describe abnormal behaviors in GD3 patients.
  • To investigate the relationship between these behaviors and demographic, neurodevelopmental, and neurological characteristics.

Main Methods:

  • Thirty-four Egyptian GD3 patients were evaluated using parent/physician reports and video recordings.
  • Behaviors were categorized into Crying/Withdrawal, Impatience/Overactivity, Anger/Aggression, and Repetitive Acts.
  • Neurologic evaluations included IQ assessment, EEG, and assessments for specific neurological signs over 3-10 years.

Main Results:

  • High prevalence of supranuclear gaze palsy (97.1%) and bulbar symptoms (50%).
  • Excessive anger (88.2%) and aggression (64.7%) were the most prominent behavioral features, more common in males.
  • Anger/Aggression scores strongly correlated with IQ, but not with seizure status or other neurologic signs.

Conclusions:

  • GD3 patients exhibit a distinct behavioral profile characterized by excessive anger and aggression.
  • Quantitative behavioral scoring may serve as a valuable marker for assessing neurologic disease progression and severity in GD3.